Envestnet Asset Management’s Columbia Research Enhanced Value ETF REVS Stock Holding History
Bought
Maintained
Sold
Other funds holding REVS
AAP
FIB
RA
SPIA
Envestnet Asset Management's REVS Position: Q2 2026 in Review
Envestnet Asset Management increased its Columbia Research Enhanced Value ETF (REVS) stake by 14% in Q2 2026, buying an estimated $1.36M and bringing the position to 361,667 shares worth $11.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1846.
Envestnet Asset Management first reported a position in REVS in Q2 2021 and has held it in 5 quarters since. 38 funds tracked by Wall St. Rank hold REVS as of Q2 2026.
- Envestnet Asset Management held 361,667 shares of Columbia Research Enhanced Value ETF worth $11.4M as of Q2 2026.
- Envestnet Asset Management bought 44,147 Columbia Research Enhanced Value ETF shares in Q2 2026, an estimated $1.36M.
- Columbia Research Enhanced Value ETF made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #1846 holding.
- Envestnet Asset Management first reported a position in Columbia Research Enhanced Value ETF in Q2 2021 and has held it in 5 quarters since.
- 38 funds tracked by Wall St. Rank held Columbia Research Enhanced Value ETF as of Q2 2026.
Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.